Most Indian drug companies that were penalised for violating US drug manufacturing norms in the last few years but have subsequently taken corrective actions are being allowed to resume sales by the US drug regulator. In the last two months, the US Food and Drug Administration (FDA) lifted the ban on drugs made at the facilities of Sun Pharma, Dr Reddy’s Laboratories and Claris Lifesciences while revoking the warning letter issued to Zydus Cadila.
